hepatitis-b

Documents about hepatitis-b

• A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.#904651ClinicalTrials.gov
• Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon#1009407ClinicalTrials.gov
• B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B#67676ClinicalTrials.gov
• Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis#125962ClinicalTrials.gov
• Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y#444760ClinicalTrials.gov
• Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y#454079ClinicalTrials.gov
• Primary liver cancer at tertiary healthcare facility in Guinea: a cross-sectional study#284225HAL (France)
• Strengthening, Guidance, Health, Empowerment#844605ClinicalTrials.gov
• Entecavir for children and adults with chronic hepatitis B.#123116NCBI PubMed Central
• Progress and challenge of hepatitis B virus mucosal vaccines.#275522NCBI PubMed Central
• A Study of SN2001 Dose, Safety & Immunogenicity in Healthy Adults#300298ClinicalTrials.gov
• Immunotherapy of Advanced Hepatitis B Related Hepatocellular Carcinoma With γδT Cells#369846ClinicalTrials.gov
• Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384#887382ClinicalTrials.gov
• Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030#151807WHO IRIS
• A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B#833597ClinicalTrials.gov
• Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure#966793ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)#1033208ClinicalTrials.gov
• Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain#860844ClinicalTrials.gov
• Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma#874976ClinicalTrials.gov
• ACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)#915992ClinicalTrials.gov
• High-contrast colorimetric NanoPCR enabled by dual-thiolated primers and machine learning for visual detection of hepatitis B virus DNA#344491HAL (France)
• Descrição clínica e epidemiológica de pacientes portadores de Hepatite B no estado de Sergipe#428337Repositório Institucional da Universidade Federal de Sergipe
• Project UNITY - HIV Risk Reduction and Vaccine Education Interventions#441977ClinicalTrials.gov
• pgRNA-m#672205PubMed
• Country guidance for planning triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus programmes#203866WHO IRIS
• Second intercountry scientific group meeting on Liver Diseases, Damascus, 4-8 February, 1984: specific screening techniques for markers of Hepatitis B infection#306749WHO IRIS
• A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis#830512ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults#343700ClinicalTrials.gov
• Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV#201611ClinicalTrials.gov
• DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease#934588Koc University Digital Collections
• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose#272399ClinicalTrials.gov
• Prospective Evaluation of a Fast-track Treatment Pathway for Patients With Chronic Hepatitis B Under Primary Care#907717ClinicalTrials.gov
• The COMBAT HBV Feasibility Trial#154722ClinicalTrials.gov
• Diagnosing and defining MASLD in people living with chronic hepatitis B.#170574NCBI PubMed Central
• Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers#279553ClinicalTrials.gov
• Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine#353342ClinicalTrials.gov
• Bioequivalence of LB80380 Free Base and Maleate Salt Tablets#845307ClinicalTrials.gov
• Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects#862876ClinicalTrials.gov
• A Study of RBD1016 in CHB Participants#885190ClinicalTrials.gov
• HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers#912989ClinicalTrials.gov
• The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF#902888ClinicalTrials.gov
• Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation#906982ClinicalTrials.gov
• Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months Schedule#910774ClinicalTrials.gov
• Hepatitis B in Africa Collaborative Network: cohort profile and analysis of baseline data#215692Ora Oxford University Research
• Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects#245558ClinicalTrials.gov
• Spatiotemporal evolution characteristics and influencing factors of hepatitis B incidence rate in China.#396144NCBI PubMed Central
• Economic case for universal hepatitis B birth dose vaccination in South Africa.#646479PubMed
• Study on Effect of Intestinal Microbiota Transplantation in Hepatitis B Virus Induced Cirrhosis#682974ClinicalTrials.gov
• Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)#830328ClinicalTrials.gov
• Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan#860007ClinicalTrials.gov